0001551306-24-000002.txt : 20240104 0001551306-24-000002.hdr.sgml : 20240104 20240104183036 ACCESSION NUMBER: 0001551306-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schlanger David J CENTRAL INDEX KEY: 0001576145 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39100 FILM NUMBER: 24513761 MAIL ADDRESS: STREET 1: C/O PROGYNY, INC. STREET 2: 1359 BROADWAY, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Progyny, Inc. CENTRAL INDEX KEY: 0001551306 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 272220139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-888-3124 MAIL ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn, Inc. DATE OF NAME CHANGE: 20150318 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn Inc DATE OF NAME CHANGE: 20120601 4 1 wk-form4_1704411024.xml FORM 4 X0508 4 2024-01-02 0 0001551306 Progyny, Inc. PGNY 0001576145 Schlanger David J C/O PROGYNY, INC. 1359 BROADWAY, 2ND FL NEW YORK NY 10018 1 1 0 0 Executive Chairman 1 Common Stock 2024-01-02 4 M 0 13998 3.9545 A 102437 D Common Stock 2024-01-02 4 S 0 13998 37.5785 D 88439 D Common Stock 2024-01-02 4 F 0 2127 37.18 D 86312 D Stock Option (Right to Buy) 3.9545 2024-01-02 4 M 0 13998 0 D 2029-05-23 Common Stock 13998 1536024 D Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. These options are fully vested and exercisable. /s/ Mark Livingston, Attorney-in-Fact 2024-01-04